Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma

J Nanobiotechnology. 2022 Feb 14;20(1):78. doi: 10.1186/s12951-022-01275-2.

Abstract

Background: Despite novel advances in screening, targeting and immunotherapies, early diagnosis and satisfactory treatments against hepatocellular carcinoma (HCC) remain formidable challenges. Given the unique advantages, carbon quantum dots (CQDs) become a smart theranostic nanomaterial for cancer diagnosis and therapy.

Results: In this work, a type of bio-friendly CQDs, trichrome-tryptophan-sorbitol CQDs (TC-WS-CQDs), is synthesized from natural biocompatible tryptophan via the one-pot hydrothermal method. Compared with normal hepatocytes, a much stronger green fluorescence is detected in HCC cells, indicating the ability of TC-WS-CQDs to target HCC cells. Furthermore, green-emitting TC-WS-CQDs generate large amounts of reactive oxygen species (ROS), leading to autophagy of HCC cells. Additionally, the green-emitting TC-WS-CQDs perform significant tumor inhibition by inducing autophagy via p53-AMPK pathway in vitro and in vivo studies with almost no systemic toxicity.

Conclusions: The results may highlight a promising anticancer nanotheranostic strategy with integration of diagnosis, targeting, and therapy.

Keywords: Carbon quantum dots; Hepatocellular carcinoma; Sorbitol; Theranostics; Tryptophan.

MeSH terms

  • Carbon / pharmacology
  • Carcinoma, Hepatocellular* / diagnostic imaging
  • Carcinoma, Hepatocellular* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Precision Medicine
  • Quantum Dots*
  • Sorbitol
  • Tryptophan

Substances

  • Sorbitol
  • Carbon
  • Tryptophan